• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Brooklyn ImmunoTherapeutics, Inc. - Common Stock (NY:BTX)

6.730 +0.090 (+1.36%)
Official Closing Price Updated: 7:00 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 470,003
Open 6.610
Bid (Size) 6.550 (1)
Ask (Size) 6.750 (1)
Prev. Close 6.640
Today's Range 6.610 - 6.745
52wk Range 5.100 - 8.120
Shares Outstanding 174,986,671
Dividend Yield 14.98%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
May 01, 2025
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
April 30, 2025
From BlackRock Closed-End Funds
Via Business Wire

Performance

YTD
-14.4%
-14.4%
1 Month
+15.0%
+15.0%
3 Month
-14.4%
-14.4%
6 Month
-14.4%
-14.4%
1 Year
-14.4%
-14.4%

More News

Read More
BlackRock Announces Shareholder Approval of Strategy Changes to the BlackRock Technology and Private Equity Term Trust (BTX)
April 17, 2025
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
March 31, 2025
From BlackRock Closed-End Funds
Via Business Wire
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
April 01, 2025
From BlackRock Closed-End Funds
Via Business Wire
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
March 03, 2025
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
February 28, 2025
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Renewal of Discount Management Programs
February 28, 2025
From BlackRock Closed-End Funds
Via Business Wire

Frequently Asked Questions

Is Brooklyn ImmunoTherapeutics, Inc. - Common Stock publicly traded?
Yes, Brooklyn ImmunoTherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Brooklyn ImmunoTherapeutics, Inc. - Common Stock trade on?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock is BTX on the New York Stock Exchange
What is the current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 6.730
When was Brooklyn ImmunoTherapeutics, Inc. - Common Stock last traded?
The last trade of Brooklyn ImmunoTherapeutics, Inc. - Common Stock was at 05/22/25 07:00 PM ET
What is the market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 1.18B
How many shares of Brooklyn ImmunoTherapeutics, Inc. - Common Stock are outstanding?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock has 1B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap